Microcosting analysis of haematopoietic stem cell transplantation and chemotherapy with intermediate doses of cytarabine in the treatment of acute myeloid leukaemia

Background: Acute myeloid leukaemia (AML) is considered a costly disease. Depending on the risk stratification, the patient may receive consolidation with cycles of intermediate doses of cytarabine, auto-HSCT or allo-HSCT according to availability in each service and the availability of a compatible...

Full description

Bibliographic Details

Main Authors:	Sitânia Chiesa, Eduardo Magalhães Rego, Vanessa Teich, Maria Isabel Ayrosa Madeira, Lorena Lobo de Figueiredo Pontes, Fabiola Traina, Leticia Olops Marani
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2024-12-01
Series:	Hematology, Transfusion and Cell Therapy
Subjects:	Acute myeloid leukaemia Autologous haematopoietic stem cell transplantation Consolidation Chemotherapy Cost Analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924000750
Tags:	Add Tag No Tags, Be the first to tag this record!